NovoCure Ltd Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NovoCure Ltd quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • NovoCure Ltd Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $28.3M, a 2.36% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $28.3M -$684K -2.36% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $29.1M +$2.8M +10.6% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $33M +$7.47M +29.2% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $34.8M +$11.2M +47.6% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $29M +$9.61M +49.5% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $26.3M +$8M +43.7% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $25.5M +$5.59M +28% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $23.6M +$5.33M +29.2% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $19.4M +$2.95M +17.9% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $18.3M +$1.32M +7.76% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $19.9M +$2.2M +12.4% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $18.3M -$742K -3.9% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $16.5M -$662K -3.87% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $17M -$465K -2.67% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $17.7M +$540K +3.14% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $19M +$1.44M +8.18% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $17.1M +$2.49M +17% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $17.4M +$2.77M +18.9% Jun 30, 2020 10-Q/A 2020-10-02
Q1 2020 $17.2M +$3.28M +23.6% Mar 31, 2020 10-Q/A 2020-10-02
Q4 2019 $17.6M +$17.6M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $14.6M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $14.7M Jun 30, 2019 10-Q 2019-07-25
Q1 2019 $13.9M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $0 Dec 31, 2018 10-Q 2019-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.